Clinical Research Directory
Browse clinical research sites, groups, and studies.
Propranolol in Capillary Hemangiomas
Sponsor: University Hospital, Bordeaux
Summary
The investigators observed that Propranolol, a beta-blocker commonly used in children was efficient to control the growth of alarming hemangiomas of the face. The primary objective of this study is to determine the efficiency of 1 month-early treatment of propranolol in infants aged less than 4 months affected by an hemangioma without any consequences on vital or functional structure and not justifying corticosteroids. The secondary objectives are: * the kinetic of the hemangioma evolution in infants treated by propranolol * Observance * Safety
Official title: Double Blind, Randomised, Placebo-controlled Study of Propranolol in Infantile Capillary Hemangiomas
Key Details
Gender
All
Age Range
Any - 4 Months
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2008-10
Completion Date
2010-04
Last Updated
2026-06-01
Healthy Volunteers
No
Conditions
Interventions
propranolol treatment
30 days-propranolol treatment : 3 mg/kg 15 days + 4 mg/kg 15 days
placebo treatment
30 days-placebo treatment : 3 mg/kg 15 days + 4 mg/kg 15 days
Locations (1)
Dermatologie Pédiatrique
Bordeaux, France